Results

eNauka >  Results >  Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension
Title: Fenebrutinib maintains early and sustained low disease activity in patients with relapsing multiple sclerosis: 2-year results from the FENopta open-label extension
Authors: Oh, Jiwon; Drulović, Jelena S. ; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Cheng, Ying-Fang; Harp, Christopher; Sierzega, Malgorzata; Clayton, David;
Ratchford, John; Goodyear, Alexandra; Bar-Or, Amit;
Issue Date: 2025
Publication: Multiple sclerosis journal (41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 24-26 Sep 2025, Barcelone, Spain)
ISSN: 1352-4585 Multiple Sclerosis Search Idenfier
Publisher: London : SAGE Publications
Type: Conference Paper
Collation: vol. 31 br. 3 Suppl str. 109-109
WoS-ID: 001603659900113
URI: https://enauka.gov.rs/handle/123456789/1016502
URL: https://journals.sagepub.com/doi/epub/10.1177/13524585251358339
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.